This is in keeping with studies which found that increased infiltration of CD163 was associated with poorer OS in hepatocellular carcinoma, triple negative breast cancer and follicular lymphoma [58, 59, 60]. The gene discussed is CD163; the disease is triple-negative breast carcinoma.